LINC01903

Across TCGA pan-cancer cohorts, LINC01903 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01903’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC01903 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01903 is over-expressed in tumor, although a few such as LUSC and KICH show the opposite, repressed pattern.

LUSC, STAD, and KICH are the cancer types where LINC01903 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01903 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.009	<.001	4	view →
STAD	Female	All	+0.025	.021	2	view →
KICH	All	All	−0.007	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC01903–LUSC

Open the LUSC breakdown →